All About Vacutainer Tubes
Historically, Vacutainer tubes in glass were invented by Joseph Kleiner in 1947. They are being manufactured and marketed by BD (Becton, Dickinson and Company) since 1949. Vacutainer is a registered trademark of Becton, Dickinson and Company. The plastic version, known as Vacutainer PLUS, was developed at Becton Dickinson Research Center, RTP, NC during 1991-1993, by co-inventors E. Vogler, D. Montgomery and G. Harper.
The first evacuated tube invented by Joseph Kleiner was called Evacutainer. BD hired Kleiner as a consultant for the product and changed the name of his tube to Vacutainer®.
Prior to the invention of an evacuated tube system, before collecting blood, solutions for the additive tubes like EDTA and citrate were prepared and dispensed into test tubes for blood anticoagulation. Then, to clarify the proper draw quantity, the laboratory used to cute lines in the borosilicate glass tubes. The phlebotomist would collect blood specimens with needles and glass syringes. After collection, the blood would be transferred into a series of test tubes and sealed the tubes with black rubber stoppers for transportation of the specimens to the laboratory. For electrolyte measurements, mineral oil was additional to the tubes to prevent loss of CO2. For serum specimens, wooden applicator sticks were used to loosen the clot from the tube walls (Franklin Lakes, 1996).
The shortcomings of these techniques were numerous. The patients were placed under the ordeal of multiple needle entries to the vein. The errors during the collection and move course of action and the safety risks were unavoidable (Franklin Lakes, 1996).
The introduction of vacuum blood collection systems marked an era of greater safety, easy handling, speed, and accuracy in blood-to-additive ratios. During blood collection with evacuated tubes, one end of the needle entered the patient’s vein; the other end penetrated the rubber stopper as the tube was pushed into the open end of the holder. The vacuum enabled the tube to fill with the appropriate quantity of blood.
Initially vacutainer tubes were packaged and shipped in vacuum tins similar to coffee cans. This was a breakthrough at the time because before, a heavy clamp was used to prevent the stoppers from popping off during autoclaving (Franklin Lakes, 1996). However, now there are regulatory agencies and guidelines that ensure the consistency in the design and manufacture of blood collection systems like Food and Drug Administration (FDA); International Standardization Organization (ISO); and Clinical Laboratory Standards Institute (CLSI); The Medical Device Amendment (1976) and the Safe Medical Devices Act (1990).
A Vacutainer tube and the apparatus consists of a plastic center, a hypodermic needle and a vacuum tube. Vacutainer tubes also contain additives to stabilize and preserve the blood specimens prior to examination. Vacutainers are obtainable with a wide range of labeling options and closure colors. They are also obtainable with a range of draw volumes with or without a safety-engineered closure.
Vacutainer tubes have found wide recognition due to their functional ease. The venipuncture protocol employing a syringe requires elaborate preparations for blood sample examination in terms of addition of appropriate additives into the tubes that carries more risks of sampling and analytical errors.
Vacutainer tubes have a color-coded plastic cap. The color code of the caps indicates the blood additives the tube contains. Additives are chemical substances that preserve the blood for processing in the laboratory.
The additives include anticoagulants like EDTA, Sodium citrate and Heparin. Some vacutainer tubes have a gel that has an intermediate density between blood cells and the serum. During centrifugation of these gel containing tubes, the blood cells sink to the bottom of the tube and are covered by a inner of the gel leaving the serum on top. When plasma containing blood platelets is required for examination a vacutainer that does not contain gel or a clotting agent is used and centrifuged. The color code has a standard protocol and hence, finds universal application across the medical domain.
The Order of Draw:
As mentioned earlier, vacutainer tubes ease multiple blood suctions and the needle that pierces multiple tubes may carry additives from one tube into the next that make difficulty the blood examination. Hence, there is need for a uniform ordern for such multiple suctions to avoid cross-contamination of additives. The Order of Draw is a term that refers to a standard protocol that has been developed for the ordern in which these tubes should be filled.
Recent Trends and Recommendations:
Recent trends in vacutainers include tubes made up of polyethylene terephthalate and use of various types of blood collection needles. Vacutainer tubes of recent introduction are made of a special formulation of the plastic, polyethylene terephthalate that is extremely strong, dimensionally stable, and resistant to chemicals and breakage. The manufacturers specify that all non-gel blood collection tubes, including those that contain heparin, EDTA and non-gel serum tubes can be centrifuged at ≤1300 RCF for 10 minutes. There are also tubes that should be spun at room temperature at a speed of 1000 to 1300 RCF for 10 minutes in a swinging bucket centrifuge and 15 minutes in a fixed-angle centrifuge.
These recent tubes are coated with silicone and micronized silica particles to accelerate clotting. A silicone coating reduces adherence of red cells to tube walls. The silica coating can sometimes cause the inner tube wall to appear cloudy and/or filmy. This cloudy turn up does not make the tubes unacceptable for use. Most Tubes are packaged 100 tubes/box and 1,000 tubes/case (10 boxes). The expiration date on the tube label is stated as a month and year. The tubes expire at the end of the month that is stated on the label. Vacutainer blood collection tubes have a sterile interior. Tubes are sterilized by gamma radiation (Wayman, 1994).
These tubes are under a specific negative pressure. During the re-sterilization cycle this negative pressure may be disrupted and consequently the tubes may not draw the proper blood quantity. consequently, these tubes are sterile on the interior only. The manufacturer does not recommend re-sterilizing the tubes with ethylene oxide or autoclaving, due to pressure changes that take place during the re-sterilization cycle. Some manufacturers do offer a sterile peel-apart pouch that contains a 10 mL glass red top serum tube and 7 mL glass lavender top EDTA tube. 3mL and 6mL plain tubes with no additional additives used as discard tubes are also obtainable and find utility when drawing blood directly from an indwelling line or catheter. The tubes should be stored at 4-25’C (39-77’F) and requires inversions after a draw. An inversion is one complete turn of the wrist, 180 degrees, and back.
Tubes should be inverted according to the following recommendations of the manufacturer:
SST and serum tubes – 5 inversions
Additive tubes (EDTA, heparin, etc) – 8-10 inversions
Sodium citrate tubes (blue top) – 3-4 inversions
The market is recently flooded with vacutainer tubes that contain a closure that has a rare rubber stopper. It is recessed within and covered by a plastic protect to help protect laboratory personnel from contact with blood on the stopper or around the outer rim of the tube. The tube closure also helps prevent blood from splattering when the tube is opened.
Vacutainers containing a gel that forms a physical obstacle between serum or plasma and blood cells during centrifugation has been introduced. It is recommended that after blood collection, Serum Separation Tubes should be inverted five times, allowed 30 minutes clotting time, and centrifuged for 10 minutes at 1000-1300 RCF (g) in a swing bucket centrifuge. Plasma Separation Tubes and should be inverted 8 times, and centrifuged for 10 minutes at 1000-1300 RCF (g) in a swing bucket centrifuge.
The gel is composed of inert elements, which are part of a polyester-based proprietary formulation. The silica particles that coat the walls of the tube are truly the clot activators. Initial activation occurs when blood enters the tube and contacts the particles on the tube wall. To continue the activation course of action, it is necessary to thoroughly mix the blood and particles by inverting the tube five times.
The coating course of action creates a film on the tube surface that appears white and slightly cloudy. The tubes are fine to use. However, it is important to remember to invert the SST™ Tube at the minimum five times after filling. This ensures adequate mixing of silica particles with the blood, which is required for optimal performance.
Serum Separation Transport Tube are tubes that contain double the amount of gel compared to the regular tubes. This provides a thick obstacle that remains intact when tubes are transported, thereby maintaining the quality of the sample for the lab examination. It is intended for use chiefly when specimens are collected and centrifuged in physician laboratories or other far away collection stations, and then transported back to the laboratory for examination.
Gel separation tubes should be centrifuged no longer than 2 hours after collection. The manufacturers do not recommend re-centrifuging gel tubes once the obstacle has formed. It is not recommended to freeze the sample in the dominant blood collection tube, on the gel obstacle. The gel may separate when it is frozen and thawed, resulting in red cell contamination of the sample. It is not recommended to use the gel tubes for any tri-cyclic antidepressant drug testing and has not been validated for trace component testing. It is recommended to use the royal blue stoppered trace component tubes for trace component testing.
EDTA Vacuum (Vacutainer)Tubes
EDTA stands for Ethylenediaminetetraacetic acid. EDTA roles by binding calcium in the blood and keeping the blood from clotting. The moderate EDTA concentration is 1.8mg EDTA per milliliter of blood. Most recent Blood Collection Tubes contain K2EDTA, which is spray-dried to the walls of the tube. K2EDTA is recommended by the CLSI (CLSI guideline – Evacuated Tubes and Additives for Blood Specimen Collection-Fifth Edition H1-A5, 2003) and the ICSH (International Council for Standardization in Hematology).
Glass blood collection tubes contain K3EDTA, the liquid form of EDTA. K3EDTA is a liquid and will dilute the sample ~ 1-2%. K2EDTA is spray-dried on the walls of the tube and will not dilute the sample. K2EDTA Tubes are intended for routine immunohematology testing, including red cell grouping, Rh typing and antibody screening. The minimum and maximum permissible blood volumes should be established by each facility, to ensure that accurate hematology results are obtained. Blood Collection Tubes are designed to draw the appropriate quantity to ensure a proper blood to additive ratio (Antignani et.al, 2001).
Sodium Citrate Tubes
Sodium citrate tubes are designed to provide within ± 10% of the stated draw quantity on the label of the additive tube throughout the complete shelf life. CLSI recommends that sodium citrate tubes be spun at 1500 RCF for 15 minutes to unprotected to platelet poor plasma (platelet count < 10, 000) and accurate coagulation test results. The etched fill indicator on the plastic citrate tubes indicates the minimum permissible blood quantity in the tube. Automated instruments require an average of 100 µl per test for PT and APTT, 50 µl for Fibrinogen, and 20 µl for Factor Assays.
There have been recent research articles suggesting that drawing a discard tube is not necessary before drawing the sodium citrate tube. In the CLSI coagulation document (H21-A5) it is nevertheless recommended that the citrate tube is the second or third tube drawn. However, in the CLSI guideline for Venipuncture Collection (H3-A6) it states that for routine PT and APTT, the first tube drawn may be used for testing. It is also important to ensure a discard tube is drawn when a blood collection set is used and only a citrate tube is ordered, as the tubing may contain up to 0.5 mL of air that will be drawn into the tube and displace blood quantity. The 1.8 mL tube has a light blue rubber stopper covered with a translucent protect and the 2.7 mL tube has a light blue rubber stopper covered with a substantial light blue closure.
Heparin is derived from porcine intestinal mucosa. The green top heparin tubes contain either the lithium or sodium salt of the heparin anticoagulant. Lithium heparin should not be used for lithium determinations. All of the heparin is spray-dried on the wall of the tube. Prior to April 1, 2010, the heparin concentration has been approximately 15 USP units of heparin per milliliter of blood. The USP is not equivalent to the International Units (IU). The IU is 6.4% greater than the USP. As of April 1, 2010, if a sodium or lithium heparin tube has a capital N superscript alphabetic character following the information Heparin (i.e.HeparinN), the USP and IU are equivalent. A numerical change in the number of USP Activity Units as a consequence of the harmonization to the WHO International Standard is displayed. When the Sodium Heparin tubes are filled to the proper quantity, the sodium results will only be 1 to 2 mmol/ mL higher (Bush et.al, 1998).
Trace component/ rule Tubes
Blood Collection Tubes can be used for monitoring Antimony, Arsenic, Cadmium, Calcium, Chromium, Copper, Iron, rule, Magnesium, Manganese and Zinc. The manufacturer offers trace component tubes with two different additives. The plastic tube contains silica particles and can be used for serum examination. The plastic trace component tube with K2EDTA, can be used for whole blood or plasma examination (Bush et.al, 1998).
SPS tubes are used for blood culture specimen collection in microbiology. Eight gentle tube inversions are recommended to prevent blood clotting. The blood can keep in the SPS tube for two to four hours before it being transferred to a blood culture bottle.
Blood Collection Kits
Push Button Blood Collection Sets and Safety Winged Blood Collection Sets are more recent innovations in the market. The Push Button Blood Collection Set and the Safety Blood Collection Set can be used with a syringe when it is used without a luer adapter. The syringe will attach to the female end of the Push Button Blood Collection Set or the Blood Collection Set. Once the blood has been drawn into the syringe, the safety mechanism on the winged needle set is properly activated. The use of any needle for the purpose of transferring blood directly from a syringe to a specimen container continues to be extremely by Federal OSHA. The syringe should be attached to a device, such as Blood move Device, that meets all procedural and safety standards for blood move. It is basic to purge the air from the tubing of a blood collection set when collecting a sodium citrate tube for PT and/or APTT testing. A plain discard tube or another sodium citrate tube should be used first to purge the air from the tubing and allow a complete draw into the citrate tube. Purging the air from the tubing is also recommended before drawing any additive tube. CLSI recommends that all additive tubes should be filled to their stated quantity. The PBBCS and SLBCS are obtainable in 21, 23 and 25 gauge needles (Bush et.al, 1998).
Vacutainer tubes are simple, easy to use, and safety-engineered. The safety mechanisms after the blood draw helps protect against needlestick injury. The tubes are also offered with a pre-attached holder for additional convenience and to help ensure OSHA single-use holder compliance.
Adcock, DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Path. 1997; 107:105-110.
Antignani A, Cheng E, Evans J, Grippi, et al. ‘Method of using additive formulation and method for making tube with an additive formulation’, U.S. Patent No. 6,187,553, February 2001.
Becton Dickinson and Company. Joseph Kleiner and the origins of the Vacutainer™. The Echo. Becton Dickinson and Company, Franklin Lakes, NJ: 1991 (Spring);11:3-5, 1991(September);11:5-7; 1996(December);16:1
Tubes are sterilized by gamma radiation (Wayman, 1994).